调节性T淋巴细胞数和CD4+T淋巴细胞内ATP水平在肾移植后免疫功能监测中的作用
摘要
随着免疫抑制剂的不断发展,器官移植后排斥反应发生率逐渐降低,受者的长期存活率得到提高,但免疫抑制过度导致感染及肿瘤的发病率却逐步上升。如何准确客观地评价受者的免疫功能状态,合理应用免疫抑制剂已成为迫切需要解决的问题。基于免疫反应发生、发展过程中涉及了细胞和分子,以下一系列监测指标,
出处
《中华器官移植杂志》
CAS
CSCD
北大核心
2012年第8期509-511,共3页
Chinese Journal of Organ Transplantation
基金
国家自然科学基金会资助课题(30872530、81072435)
江苏省医学重点学科资助项目(XK201151)
江苏省医学领军人才项目(LJ201138)
苏州市科技基础设施建设计划项目(SZS201001、SZS0702)
参考文献28
-
1Sakaguchi S. Naturally arising Foxp3-expressing CD25^+ CD4 + regulatory T cells in immunological tolerance to self and non- self. Nat Immunol, 2005, 6(4) :345-352.
-
2周晓慧,范慧敏,S.G.Zheng,刘中民.调节性T淋巴细胞在移植免疫耐受中的作用研究进展[J].中华器官移植杂志,2008,29(9):573-575. 被引量:1
-
3Newell KA, Phippard D, Turka LA. Regulatory cells and cell signatures in clinical transplantation tolerance. Curr Opin Immunol, 2011, 23(5) :655-659.
-
4Seddiki N, Santner-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and 1L-7 receptors discriminates between human regulatory and activated T cells. J Exp Med, 2006, 203 (7) : 1693-1700.
-
5Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells. J Exp Med, 2006, 203 (7):1701- 1711.
-
6Veronese F, Rotman S, Smith RN, et al. Pathological and clinical correlates of FOXP3 + cells in renal allografts during acute rejection. Am J Transplant, 2007, 7(4):914-922.
-
7Martin L, Funes de la Vega M, Bocrie O, et al. Detection of Foxp3 + cells on biopsies of kidney transplants with early acute rejection. Transplant Proc, 2007, 39(8):2586-2588.
-
8Muthukumar T, Dadhania D, Ding R, et al. Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med, 2005, 353(22) :2342-2351.
-
9Karczewski M, Karczewski J, Kostrzewa A, et al. The role of Foxp3 + regulatory T cells in kidney transplantation. Transplant Proc, 2009, 41 (5) : 1527-1529..
-
10Akl A, Jones ND, Rogers N, et al. An investigation to assess the potential of CD25highCD4+ T cells to regulate responses to donor alloantlgens in clinically stable renal transplant recipients. Transpl Int, 2008, 21 ( 1 ) : 65-73.
二级参考文献27
-
1Banham AH. Cell-surface IL-7 receptor expression facilitates the purification of FOXP3 ( + ) regulatory T cells. Trends Immunol, 2006, 27(12):541-544
-
2Deaglio S, Dwyer KM, Gao W, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med, 2007, 2114 (6) : 1257 -1265.
-
3Baatar D. Olkhanud P. Sumitomo K. et al. Human peripheral blood T regulatory cells (Tregs), funclionally primed CCR4 + Tregs and unprimed CCR4- Tregs, regulate effector T cells using FasL. J Immunol, 2007, 178(8):4891-4900
-
4Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003, 299(561)9) : 1057-11161.
-
5Tran DQ, Ramsey H, Shevach EM. Induction of FOXP3 expression in naive human CD4+ FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood, 2007, 110(8): 2983-2990.
-
6Du J, Huang C, Zhou B, et al. Isoform-specific inhibition of ROR alpha-mediated transcriptional activation by human FOXP3. J Immunol, 2008, 180(7) :4785-4792.
-
7Liu W, Putnam AI., Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med, 2006, 2113(7): 1701-1711.
-
8Seddiki N, Sanmer-Nanan B, Martinson J, et al. Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med, 2006, 203(7) : 1693-1700.
-
9Hartigan-O'Connor DJ, Poon C, Sinclair E. et al. Human CD4 + regulatory T cells express lower levels of the IL-7 receptor alpha chain (CD127). allowing consistent identification and sorting of live cells. J Immunol Methods, 2007, 319 (1- 2) : 41-52.
-
10Zheng SG, Meng L, Wang JH, et al. Transfer of regulatory T cells generated ex vivo modifies graft rejection through induction of tolerogenic CD4 + CD25 + cells in the recipient. Int Immunol, 2006, 18(2) :279-289.
-
1王慧琴,刘景生.阿片类物质对淋巴细胞内环磷酸腺苷及游离钙的影响[J].基础医学与临床,1993,13(4):30-34.
-
2马玉奎,卢实春,李波,严律南,林琦远.常规剂量他克莫司导致肝移植患者免疫抑制过度一例[J].中华器官移植杂志,2003,24(1):30-30. 被引量:7
-
3孔令提,刘冬,宋春丽,邢蓉.抗血小板药物临床个体化给药中存在的问题及其研究进展[J].中国药房,2015,26(20):2878-2880. 被引量:2
-
4陈小莉,宋绍团,张三虎.瑞芬太尼与丙泊酚靶控输注用于老年患者结肠镜检查的临床观察[J].中国医学创新,2011,8(7):25-26. 被引量:1
-
5牟静,傅晓华,任斌,唐蕾.西罗莫司治疗肾移植后排斥反应的疗效、不良反应与其血药浓度的相关性分析[J].中国药房,2011,22(30):2839-2841. 被引量:6
-
6抗癌药可降低肾移植后排斥[J].中国家庭医生,2009(5):51-51.
-
7王燕慧,裴一璇,张灏.氯吡格雷抵抗的检测和治疗策略[J].国际药学研究杂志,2013,40(4):435-438. 被引量:3
-
8顾觉奋,孙业平.微生物来源的免疫抑制剂及其作用机制[J].药学进展,2001,25(1):7-11. 被引量:5
-
9贾丽红,赵越,陆春伟,钱聪,扬军,孙贵范.维生素C拮抗氟抑制体外培养淋巴细胞抗氧化酶活性的研究[J].中国公共卫生,2001,17(7):646-647. 被引量:3
-
10何建新,易绍东,邱建.比索洛尔对心力衰竭患者心功能及血淋巴细胞内游离钙浓度的影响[J].心脏杂志,2002,14(1):16-18. 被引量:1